• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $BTI

    British American Tobacco Industries p.l.c.

    Subscribe to $BTI
    $BTI
    Medicinal Chemicals and Botanical Products
    Health Care

    British American Tobacco p.l.c. provides tobacco and nicotine products to consumers worldwide. It offers vapour products, tobacco heating products, and modern oral products; combustible products; and traditional oral products, such as Swedish-style snus and American moist snuff. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

    IPO Year: 1998

    Exchange: NYSE

    Website: bat.com

    Peers

    $PM
    $UL

    Recent Analyst Ratings for British American Tobacco Industries p.l.c.

    DatePrice TargetRatingAnalyst
    4/30/2025Buy
    BofA Securities
    1/27/2025Neutral → Buy
    UBS
    10/3/2024$33.00Overweight → Underweight
    Morgan Stanley
    1/23/2024Neutral
    UBS
    11/1/2023$38.00Overweight
    Morgan Stanley
    9/25/2023Buy
    Citigroup
    9/1/2023Buy → Hold
    Argus
    3/13/2023Overweight → Neutral
    JP Morgan
    11/2/2022Buy → Neutral
    Goldman
    3/24/2022Neutral → Overweight
    JP Morgan
    See more ratings

    British American Tobacco Industries p.l.c. Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Bt De Investments Inc.

      3 - British American Tobacco p.l.c. (0001303523) (Reporting)

      11/23/22 4:29:54 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    British American Tobacco Industries p.l.c. Leadership Updates

    Live Leadership Updates

    See more
    • British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

      1/24/24 6:21:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

      Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web.  CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C

      9/13/23 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • GREENBUTTS APPPOINTS FORMER BIG TOBACCO EXECUTIVE AS CHIEF STRATEGY OFFICER

      SAN DIEGO, Calif., June 22, 2022 /PRNewswire/ - Greenbutts, LLC (the "Company" or "Greenbutts") is pleased to announce the appointment of Luis Sanches as the Company's Chief Strategy Officer effective immediately. Luis is a Senior Corporate Executive with more than 30 years of international, cross functional and cross-cultural experience responsible for managing business teams, supporting growth, and leading transformations across multiple geographies such as Australasia, North and South America, and Europe. He was previously the Senior Vice President of R&D for Reynolds Ameri

      6/22/22 2:34:00 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Dorman Announces the Appointment of J. Darrell Thomas to its Board Of Directors

      COLMAR, Pa., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Dorman Products, Inc. (the "Company") (NASDAQ:DORM) today announced that J. Darrell Thomas has been appointed as an independent director to the Company's Board of Directors, effective October 30, 2021. Mr. Thomas' appointment expands the Board to nine directors, seven of whom are independent directors. Mr. Thomas will be a member of the Company's Audit, Compensation and Corporate Governance and Nominating committees. Mr. Thomas currently serves as Vice President and Treasurer for Harley-Davidson, Inc. (NYSE:HOG), which he joined in June 2010. During his tenure at Harley-Davidson, he also has served in several other senior finance positions, i

      11/2/21 7:00:00 AM ET
      $BTI
      $DORM
      $HOG
      Medicinal Chemicals and Botanical Products
      Health Care
      Auto Parts:O.E.M.
      Consumer Discretionary

    British American Tobacco Industries p.l.c. SEC Filings

    See more
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/9/25 11:07:44 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/6/25 12:33:01 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      5/1/25 7:49:52 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      4/29/25 12:20:50 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      4/28/25 11:24:08 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      4/23/25 11:33:07 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      4/22/25 1:48:53 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SD filed by British American Tobacco Industries p.l.c.

      SD - British American Tobacco p.l.c. (0001303523) (Filer)

      4/17/25 8:09:42 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      4/16/25 3:22:36 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 6-K filed by British American Tobacco Industries p.l.c.

      6-K - British American Tobacco p.l.c. (0001303523) (Filer)

      4/14/25 8:07:05 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    British American Tobacco Industries p.l.c. Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/9/24 6:03:23 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/9/24 5:46:32 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      1/26/24 4:56:06 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      12/8/23 5:05:27 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G filed by British American Tobacco Industries p.l.c.

      SC 13G - British American Tobacco p.l.c. (0001303523) (Subject)

      2/13/23 3:54:30 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G filed by British American Tobacco Industries p.l.c.

      SC 13G - British American Tobacco p.l.c. (0001303523) (Subject)

      2/13/23 3:32:24 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/10/23 3:01:35 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/11/22 11:19:49 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G/A filed by British American Tobacco Industries p.l.c. (Amendment)

      SC 13G/A - British American Tobacco p.l.c. (0001303523) (Subject)

      2/10/22 4:06:25 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form SC 13G filed

      SC 13G - British American Tobacco p.l.c. (0001303523) (Subject)

      2/16/21 3:58:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    British American Tobacco Industries p.l.c. Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • BofA Securities resumed coverage on British American Tobacco

      BofA Securities resumed coverage of British American Tobacco with a rating of Buy

      4/30/25 9:01:21 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco upgraded by UBS

      UBS upgraded British American Tobacco from Neutral to Buy

      1/27/25 7:35:54 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded British American Tobacco from Overweight to Underweight and set a new price target of $33.00

      10/3/24 7:24:54 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • UBS resumed coverage on British American Tobacco

      UBS resumed coverage of British American Tobacco with a rating of Neutral

      1/23/24 7:13:51 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Morgan Stanley initiated coverage on British American Tobacco with a new price target

      Morgan Stanley initiated coverage of British American Tobacco with a rating of Overweight and set a new price target of $38.00

      11/1/23 6:11:46 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Citigroup resumed coverage on British American Tobacco

      Citigroup resumed coverage of British American Tobacco with a rating of Buy

      9/25/23 7:46:56 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco downgraded by Argus

      Argus downgraded British American Tobacco from Buy to Hold

      9/1/23 7:35:36 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco downgraded by JP Morgan

      JP Morgan downgraded British American Tobacco from Overweight to Neutral

      3/13/23 7:21:18 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco downgraded by Goldman

      Goldman downgraded British American Tobacco from Buy to Neutral

      11/2/22 6:10:50 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco upgraded by JP Morgan

      JP Morgan upgraded British American Tobacco from Neutral to Overweight

      3/24/22 7:11:20 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    British American Tobacco Industries p.l.c. Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Charlotte's Web Reports 2024 First Quarter Financial Results

      LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

      5/8/24 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • British American Tobacco p.l.c investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2024 deadline

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises British American Tobacco p.l.c (NYSE:BTI) investors that a lawsuit was filed on behalf of investors that purchased BTI securities between February 9, 2023 and December 6, 2023, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing cla

      1/24/24 6:21:08 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Organigram Announces C$124.6 Million Investment from BAT and Creation of "Jupiter" Strategic Investment Pool

      Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued over three tranches Organigram to use C$83.1 million of the investment to create "Jupiter," a strategic investment pool designed to expand Organigram's geographic footprint and capitalize on emerging growth opportunities C$41.5 million of the investment will be used for general corporate purposes Investment enhances strategic Product Development Collaboration between BAT and Organigram, which focuses on cutting-edge R&D and product innovation BAT to increase voting Common Share ownership position to 30% and overall equity interest to 45% (including non-voting Class A P

      11/6/23 6:00:00 AM ET
      $BTI
      $OGI
      Medicinal Chemicals and Botanical Products
      Health Care
      Biotechnology: Pharmaceutical Preparations
    • Charlotte's Web Announces Appointment of Bill Morachnick as Chief Executive Officer

      Provides Update on Majority Voting Policy Process LOUISVILLE, Colo., Sept. 13, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company") is pleased to announce the appointment of William (Bill) Morachnick who has joined the Company as its Chief Executive Officer. Mr. Morachnick has also been appointed to the Company's Board of Directors as a non-independent director. He replaces CEO Jacques Tortoroli who has elected to resign from his roles at Charlotte's Web.  CWEB) (OTCQX:CWBHF):. The World's Most Trusted Hemp Extract and Official CBD of Major League Baseball (MLB). (C

      9/13/23 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 Second Quarter Financial Results

      Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.  Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.

      8/10/23 7:33:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 First Quarter Financial Results

      Net cash of $61MNet revenue of $17M decreased 12.1% YoY14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-ye

      5/12/23 7:05:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web forms Joint Venture with BAT and AJNA BioSciences to Seek FDA-Approval for Proprietary Full Spectrum Hemp Extract Botanical Drug

      BAT acquires 20% stake for US$10 million, with Charlotte's Web and AJNA each owning 40% Renowned neurologist Dr. Orrin Devinsky, Chief Medical Advisor for AJNA, to lead the project DENVER, April 6, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web," "CW" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today announced it has formed a joint venture (the "JV") with AJNA BioSciences PBC ("AJNA"), a botanical drug development company focused on mental health and neurological disorders , and a subsidiary of British American Tobacco PLC (NYSE:BTI) ("BAT"), which is contributing US$10 million as the JV's initial inve

      4/6/23 10:46:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2022 Fourth Quarter And Year-End Financial Results

      28% reduction in 12-month operating expenses Net cash of $67M at December 31, 2022 LOUISVILLE, Colo., March 23, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in United States dollars unless otherwise indicated. Percentage changes are calculated to the nearest thousand dollars. "In the fourth quarter, Charlotte's Web cemented an a

      3/23/23 6:30:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Announces US$56.8 Million Investment from BAT

      Investment Will Help Drive Growth and Deepen R&D DENVER, Nov. 15, 2022 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF) Charlotte's Web Holdings, Inc. ("Charlotte's Web," or the "Company") the market leader in hemp-derived cannabidiol ("CBD") wellness products, today announced a US$56.8 million investment (the "Investment") from a subsidiary of BAT (LSE: BATS) and (NYSE:BTI), which provides the Company with incremental capital to fund growth initiatives, including the Company's expanding portfolio of botanical wellness products. CWEB) (OTCQX:CWBHF) announces strategic investment from BAT (NYSE:BTI) (CNW Group/Charlotte's Web Holdings

      11/15/22 5:05:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • GREENBUTTS APPPOINTS FORMER BIG TOBACCO EXECUTIVE AS CHIEF STRATEGY OFFICER

      SAN DIEGO, Calif., June 22, 2022 /PRNewswire/ - Greenbutts, LLC (the "Company" or "Greenbutts") is pleased to announce the appointment of Luis Sanches as the Company's Chief Strategy Officer effective immediately. Luis is a Senior Corporate Executive with more than 30 years of international, cross functional and cross-cultural experience responsible for managing business teams, supporting growth, and leading transformations across multiple geographies such as Australasia, North and South America, and Europe. He was previously the Senior Vice President of R&D for Reynolds Ameri

      6/22/22 2:34:00 PM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care

    British American Tobacco Industries p.l.c. Financials

    Live finance-specific insights

    See more
    • Charlotte's Web Reports 2024 First Quarter Financial Results

      LOUISVILLE, Colo., May 8, 2024 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full-spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2024. "The first quarter of 2024 started slowly in terms of sales volume. This is being addressed with solid progress in our 'True North' turnaround initiatives," said Bill Morachnick, Chief Executive Officer of Charlotte's Web. "For example, our legacy e-commerce platform limits our ability to be agile

      5/8/24 7:07:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 Second Quarter Financial Results

      Encouraging CBD regulatory progress in CongressNet revenue of $16.0M vs. $18.9M YoYCash increased to $61.7M LOUISVILLE, Colo., Aug. 10, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the second quarter ended June 30, 2023.  Regulatory Update During the second quarter, the U.S. Food and Drug Administration ("FDA") committed to "work at speed" with Congress to resolve a regulatory pathway for hemp-derived CBD.

      8/10/23 7:33:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2023 First Quarter Financial Results

      Net cash of $61MNet revenue of $17M decreased 12.1% YoY14% YoY reduction in operating expenses LOUISVILLE, Colo., May 12, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the first quarter ended March 31, 2023. "In the first quarter, we maintained prudent cost controls to balance softness in the CBD category due to the unregulated environment. We successfully reduced operating expenses by 14% on a year-over-ye

      5/12/23 7:05:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care
    • Charlotte's Web Reports 2022 Fourth Quarter And Year-End Financial Results

      28% reduction in 12-month operating expenses Net cash of $67M at December 31, 2022 LOUISVILLE, Colo., March 23, 2023 /PRNewswire/ - (TSX:CWEB) (OTCQX:CWBHF), Charlotte's Web Holdings, Inc. ("Charlotte's Web" or the "Company"), the market leader in full spectrum hemp extract wellness products, today reported financial results for the fourth quarter and year ended December 31, 2022. All amounts are expressed in United States dollars unless otherwise indicated. Percentage changes are calculated to the nearest thousand dollars. "In the fourth quarter, Charlotte's Web cemented an a

      3/23/23 6:30:00 AM ET
      $BTI
      Medicinal Chemicals and Botanical Products
      Health Care